MWNA
QTTB icon

Marshall Wace North America’s Q32 Bio QTTB Stock Holding History

Marshall Wace North America’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-643
Closed -$226K – 1585
2019
Q2 		$226K Sell
643
-4,530
-88% -$1.78M ﹤0.01% 1020
2019
Q1 		$2.58M Buy
+5,173
New +$2.31M 0.02% 447

Other funds holding QTTB

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Marshall Wace North America's QTTB Position: Q3 2019 in Review

Marshall Wace North America sold out of Q32 Bio (QTTB) in Q3 2019, closing a stake of 643 shares — an estimated $226K sold.

Marshall Wace North America first reported a position in QTTB in Q1 2019 and held it in 2 quarters. The position peaked at $2.58M in Q1 2019. 80 funds tracked by Wall St. Rank hold QTTB as of Q3 2019.

  • Marshall Wace North America reported no remaining Q32 Bio position as of Q3 2019 after selling out during the quarter.
  • Marshall Wace North America sold 643 Q32 Bio shares in Q3 2019, an estimated $226K.
  • Marshall Wace North America first reported a position in Q32 Bio in Q1 2019 and held it in 2 quarters.
  • Marshall Wace North America's Q32 Bio position peaked at $2.58M in Q1 2019.
  • 80 funds tracked by Wall St. Rank held Q32 Bio as of Q3 2019.

Based on Marshall Wace North America's 13F filing for Q3 2019, filed 14 Nov 2019.